Prosecution Insights
Last updated: April 19, 2026

Otsuka Pharmaceutical Co. Ltd.

18 pending office actions

Portfolio Summary

18
Total Pending OAs
7
Final Rejections
11
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19220457 METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS KUCHARCZK, JED A 1623 Non-Final OA May 28, 2025
18744247 KAEMPFEROL ANALOG-CONTAINING COMPOSITION MCINTOSH III, TRAVISS C 1693 Non-Final OA Jun 14, 2024
18683025 INFORMATION PROVISION METHOD FOR PREDICTING HEALTH CONDITION OF CONSUMER AND SUPPORTING HEALTH MAINTENANCE AND IMPROVEMENT HEIN, DEVIN C 3686 Non-Final OA Feb 12, 2024
18573785 COMPOSITION FOR SUPPRESSING MUSCLE DAMAGE AULAKH, CHARANJIT 1621 Non-Final OA Dec 26, 2023
18569850 AZABICYCLO[3.1.0]HEXANE COMPOUND JARRELL, NOBLE E 1699 Non-Final OA Dec 13, 2023
18546602 AMORPHOUS FORM AND COMPOSITION CONTAINING SAID AMORPHOUS FORM SASAN, ARADHANA 1615 Final Rejection Aug 16, 2023
18304396 LOW DOSE COMBINATION CDA SUBSTRATE DRUG/CEDAZURIDINE WITH EXTENDED ADMINISTRATION BAKSHI, PANCHAM 1623 Final Rejection Apr 21, 2023
18023211 KAEMPFEROL AGLYCONE-CONTAINING EXTRACT DAHLIN, HEATHER RAQUEL 1629 Non-Final OA Feb 24, 2023
18042503 CRYSTALLINE FORM OF HETEROBICYCLIC COMPOUND SHOWALTER, ALEXANDER KEITH 1629 Final Rejection Feb 22, 2023
18042167 BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS KAPUSHOC, STEPHEN THOMAS 1683 Non-Final OA Feb 17, 2023
18006969 BLADDER ORGANOID AND METHOD FOR PRODUCING SAME WILSON, MICHAEL C 1638 Non-Final OA Jan 26, 2023
17757843 BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS LEE, CHIHYI NMN 1628 Non-Final OA Jun 22, 2022
17755832 ORALLY DISINTEGRATING TABLET KNIGHT, SAMANTHA JO 1614 Non-Final OA Jun 10, 2022
17762481 DETECTION METHOD AND DETECTION DEVICE GERIDO, DWAN A 1797 Final Rejection Mar 22, 2022
17606276 HIGH VISCOSITY O/W EMULSION COMPOSITION CONTAINING ADENOSINE PHOSPHATE BERRIOS, JENNIFER A 1613 Final Rejection Oct 25, 2021
17433904 COMPOSITION CONTAINING PLANT-DERIVED EXTRACT AND/OR PLANT-DERIVED PROCESSED PRODUCT CLARK, AMY LYNN 1628 Final Rejection Aug 25, 2021
17397911 AMELIORATING AGENT FOR FEMALE-SPECIFIC PHYSICAL AND/OR MENTAL UNPLEASANT SYMPTOM BARSKY, JARED 1628 Non-Final OA Aug 09, 2021
16863187 EQUOL-CONTAINING EXTRACT, METHOD FOR PRODUCTION THEREOF, METHOD FOR EXTRACTION OF EQUOL, AND EQUOL-CONTAINING FOOD LANDAU, SHARMILA GOLLAMUDI 1653 Final Rejection Apr 30, 2020

Managing Otsuka Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month